ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory … – GlobeNewswire (press release)

Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory …GlobeNewswire (press release)SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc., a San Diego-based company translating be… Continue reading

2018-04-26 Michael Zand NEWS

Better lung cancer treatment? Immunotherapy drug Keytruda boosts effectiveness of chemotherapy in trial – Genetic Literacy Project

Continue reading

2018-04-26 Michael Zand NEWS

CrownBio Launches New Humanized Target Model for Immunotherapy – GlobeNewswire (press release)

GlobeNewswire (press release)CrownBio Launches New Humanized Target Model for ImmunotherapyGlobeNewswire (press release)SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (… Continue reading

2018-04-26 Michael Zand NEWS

The Million Dollar Cancer Treatment: Who Will Pay? – Wall Street Journal


Genetic Literacy Project

Better lung cancer treatment? Immunotherapy drug Keytruda boosts effectiveness of chemotherapy in trial
Genetic Literacy Project
A widely used immunotherapy drug appears to be useful in a greater number of patients with lung cancer. The drug called Keytruda, or pembrolizumab, is already prescribed to a group of patients who have a type of malignancy called non-small cell lung …
‘This is not experimental anymore’: How immunotherapy is being used for some lung cancer and melanoma patientsCBC.ca
New hope for stage 4 lung cancer patientsFoster’s Daily Democrat

all 3 news articles »

Continue reading

2018-04-26 Michael Zand NEWS

Merck KGaA secures CRISPR patent in China – Life Sciences Intellectual Property Review

Merck KGaA secures CRISPR patent in ChinaLife Sciences Intellectual Property ReviewWith a 13-year history in the genome-editing field, Merck KGaA has related patent filings for its “insertion CRISPR method” in the US, Brazil, India and Japan. The compa… Continue reading

2018-04-26 Michael Zand NEWS

Merck KGaA secures CRISPR patent in China – Life Sciences Intellectual Property Review

Merck KGaA secures CRISPR patent in ChinaLife Sciences Intellectual Property ReviewWith a 13-year history in the genome-editing field, Merck KGaA has related patent filings for its “insertion CRISPR method” in the US, Brazil, India and Japan. The compa… Continue reading

2018-04-26 Michael Zand NEWS

CRISPR Wizard Feng Zhang: The Making Of A Sunny Science Superstar – WBUR


Wall Street Journal

The Million Dollar Cancer Treatment: Who Will Pay?
Wall Street Journal
In January, he got a drug called Neupogen to boost his white blood cells. And he has regular follow-ups to make sure he doesn’t have lasting neurological effects. “Already hit my total out-of-pocket of $5,000 for this year,” Mr. Fries said in March. He …

Continue reading

2018-04-26 Michael Zand NEWS

‘Desperation Oncology’: When Patients Are Dying, Some Cancer Doctors Turn to Immunotherapy – New York Times


WBUR

CRISPR Wizard Feng Zhang: The Making Of A Sunny Science Superstar
WBUR
“Feng is a one-in-a-generation scientist who sees connections that the rest of us have overlooked,” says Robert Desimone, director of the McGovern Institute for Brain Research at MIT. “And by seeing those new connections, he’s able to make these …

Continue reading

2018-04-26 Michael Zand NEWS
  • 1
  • …
  • 191
  • 192
  • 193
  • 194
  • 195
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

New York Times

‘Desperation Oncology’: When Patients Are Dying, Some Cancer Doctors Turn to Immunotherapy
New York Times
Dr. Oliver Sartor has a provocative question for patients who are running out of time. Most are dying of prostate cancer. They have tried every standard treatment, to no avail. New immunotherapy drugs, which can work miracles against a few types of …